Cefpodoxime Dosing for Pediatric UTI
For children with uncomplicated urinary tract infections, cefpodoxime should be dosed at 10 mg/kg/day divided into two doses (5 mg/kg every 12 hours) for 7-14 days, with dose adjustments required for moderate to severe renal impairment.
Standard Dosing Recommendations
The FDA-approved dosing for pediatric UTI is 10 mg/kg per day divided in 2 doses (cefpodoxime proxetil tablets) 1. This translates to approximately 5 mg/kg every 12 hours, not to exceed adult dosing.
Treatment Duration
- 7 to 14 days is the recommended duration for febrile UTIs in children 2
- The 2011 AAP guideline acknowledges this range but notes that direct comparative data between 7,10, and 14 days are lacking
- Minimum 7 days is essential, as 1-3 day courses have proven inferior 2
Renal Impairment Adjustments
Cefpodoxime requires dose modification in renal dysfunction because it is primarily renally eliminated 1, 3:
Dosing by Creatinine Clearance:
- CrCl ≥50 mL/min: Standard dosing (no adjustment needed)
- CrCl 30-49 mL/min (moderate impairment): Increase dosing interval to every 24 hours 1
- CrCl <30 mL/min (severe impairment): Increase dosing interval to every 24 hours 1
- Hemodialysis patients: Dose 3 times per week after dialysis 1
Pharmacokinetic Rationale:
Studies demonstrate that cefpodoxime half-life increases significantly with declining renal function: from 2.55 hours in normal function to 9.8 hours in severe impairment 3. The drug's total body clearance correlates directly with creatinine clearance (CLP/F = 1.9 × CrCl + 18.4) 3.
Clinical Context and Alternatives
Position Among Treatment Options:
While cefpodoxime is FDA-approved for pediatric UTI, it is not a first-line agent. The 2011 AAP UTI guideline lists cefpodoxime as an acceptable oral option but emphasizes:
- First-line oral agents: Amoxicillin-clavulanate, cephalexin, or trimethoprim-sulfamethoxazole (based on local resistance patterns) 2
- Cefpodoxime is listed as an alternative oral cephalosporin alongside cefixime, cefprozil, and cefuroxime axetil 2
When to Consider Cefpodoxime:
- Documented resistance or allergy to first-line agents
- Local resistance patterns favor third-generation cephalosporins
- Step-down therapy after initial parenteral treatment
Important Caveat:
Nitrofurantoin should NOT be used for febrile UTIs in children, as it does not achieve adequate tissue concentrations to treat pyelonephritis 2. This is a common prescribing error.
Administration Considerations
- Give with food to enhance absorption 1
- Cefpodoxime demonstrates dose-dependent absorption with decreased bioavailability at higher doses 1
- Peak concentrations occur at 2-3 hours post-dose 1
- The drug achieves adequate urinary concentrations even at lower doses due to renal excretion 1
Monitoring and Safety
No hepatic dose adjustment needed in cirrhotic patients 1. Common adverse effects include:
- Diarrhea (7%, dose-related) 1
- Nausea (3.3%) 1
- C. difficile was detected in 10% of patients with diarrhea 1
Critical warning: If severe diarrhea develops, consider pseudomembranous colitis and discontinue therapy 1.